Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Genmab A (GNMSF) Shares Outstanding (Weighted Average) (2024 - 2025)

Historic Shares Outstanding (Weighted Average) for Genmab A (GNMSF) over the last 2 years, with Q4 2025 value amounting to $15.5 million.

  • Genmab A's Shares Outstanding (Weighted Average) fell 1223.1% to $15.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $15.5 million, marking a year-over-year decrease of 1223.1%. This contributed to the annual value of $15.5 million for FY2025, which is 1223.1% down from last year.
  • Latest data reveals that Genmab A reported Shares Outstanding (Weighted Average) of $15.5 million as of Q4 2025, which was down 1223.1% from $15.0 million recorded in Q3 2025.
  • Genmab A's 5-year Shares Outstanding (Weighted Average) high stood at $17.7 million for Q1 2024, and its period low was $3.1 million during Q1 2025.